Through binding to its ubiquitous receptors, IL-17 plays a crucial role in the propagation of inflammation, leading to the development of a low-grade chronic inflammation within AT and contributing to chronic inflammatory diseases associated with obesity. Here, IL17A is linked to obesity disorder.